Evaluating a High-Dose vs. Standard-Dose Hepatitis B Vaccine Series in Patients Living With HIV
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
The Women Informational Network (WIN) micro-grant initiative supports grassroots, women-led, community-based organizations and leaders conducting innovative approaches that reduce isolation and stigma for women of color with HIV, with a special emphasis placed on women with HIV living in rural areas and ‘resource deserts’ not connected to care.
Resource (Conference Presentation) updated 09/14/2023
In this workshop, participants will gain resources and strategies for implementing community engagement programs, including training community health workers to be part of a health care team to enhance viral suppression and management of HIV in rural populations.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 03/15/2023
Resource updated 09/14/2023
Resource updated 04/07/2023
Resource updated 04/10/2023
The purpose of the ESCALATE training program is to facilitate transformative and relational change in Ryan White HIV/AIDS Programs (RWHAP) and the communities they serve. This is a Glossary of commonly used terms under in the ESCALATE capacity-building initiative.
Resource updated 05/14/2024
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource updated 02/28/2023
Resource updated 03/04/2024
Resource updated 09/20/2023
Resource updated 05/15/2024
Resource from the RWHAP Best Practices Compilation updated on 05/15/2024
Resource updated 10/24/2023
Resource updated 11/29/2023
Resource (Conference Presentation) updated 09/14/2023
Use of patient-reported outcome measures (PROMS) and patient-reported experience measures (PREMS) to help guide quality improvement activities by utilizing the patient voices and input.
Resource (Conference Presentation) updated 09/14/2023
Barriers and facilitators to HCV treatment during the DAA era for the understudied and high-risk population of HIV/HCV co-infected patients who delay or do not consent to treatment, and interventions for increasing DAA treatment uptake.
Resource (Conference Presentation) updated 09/14/2023